The agency lifted the clinical hold after reviewing additional information related to the product candidates’ delivery devices. The company said that the US clinical development of these product
The one-month, prospective, multicentre, open-label Phase II trial enrolled a total of 39 pediatric patients in the US and is designed to characterize safety, procedural factors and clinical
Zykadia is an oral, selective inhibitor of ALK, a gene that can fuse with others to form an abnormal fusion protein that promotes the development and growth of
Under the public-private partnership (PPP), research scientists from both parties will work together in an HIV Cure center, which will be located at UNC. The two entities will
As part of the deal, Thermo Fisher will further offer Horizon’s X-MAN haploid cell line generation service to its worldwide customer base with the exception of Japan. Horizon’s
Latuda is an atypical antipsychotic developed by Sumitomo, while it is characterized by a chemical structure and an affinity for dopamine D2, serotonin 5-HT2A and serotonin 5-HT7 receptors
The proposed transaction also includes BASF’s production sites in Minden, Germany, Evionnaz, Switzerland, and Saint-Vulbas, France. About 850 positions globally are in the scope of the transaction and
Under the deal, Cyclenium’s CMRT Technology-derived QUEST Library and associated hit-to-lead optimization expertise will be combined with Haplogen’s haploid genetics technology and expertise in host target identification, validation
Despite causing kidney toxicity, gentamicin has become one of the most commonly prescribed hospital antibiotics. The product drug consists of a mixture of distinct but closely related chemical
The agency has also accepted the company’s investigational new drug (IND) application to begin a Phase II trial of cobiprostone to prevent oral mucositis in patients suffering with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.